Intensification of Basal Insulin Therapy with Lixisenatide in Patients with Type 2 Diabetes in a Real-World Setting: The BASAL-LIXI Study

• প্রধান লেখক: Diego Bellido, MD, PhD (লেখক), Pablo Abellán, MD, PhD (লেখক), José Manuel Ruiz Palomar, MD (লেখক), Rogelio Álvarez Sintes, MD (লেখক), Andreu Nubiolae, MD (লেখক), Virginia Bellido, MD, PhD (লেখক), Gracia Romero, PhD (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Elsevier, 2018-01-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

ABSTRACT: Background: Basal insulin reduces fasting blood glucose levels, but postprandial blood glucose levels may remain higher. Traditional strategies with rapid insulin intensification can cause hypoglycemic episodes and weight gain. Glucagon-like peptide-1 receptor agonists, such as the short-a...